Article

Tumor cell intrinsic and extrinsic features predicts prognosis in estrogen receptor positive breast cancer

2021-09-30

Abstract excerpt

Although estrogen-receptor-positive (ER+) breast cancer is generally associated with favorable prognosis, clinical outcome varies substantially among patients. Genomic assays have been developed and applied to predict patient prognosis for personalized treatment. We hypothesize that the recurrence risk of ER+ breast cancer patients is determined by both genomic mutations intrinsic to tumor cells and extrinsic immu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1cf3be49-63de-599b-ba91-fd06c65b1f94
DOI: 10.1101/2021.09.29.462286

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumor cell intrinsic and extrinsic features predicts prognosis in estrogen receptor positive breast cancerDOI 10.1101/2021.09.29.462286Read

Tumor Cell Intrinsic And Extrinsic Features Predicts Prognosis In Estrogen Receptor Positive Breast CancerSemantic proximity Read

Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.Semantic proximity Read

A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscapeSemantic proximity Read

Genomic Features of Rapid Versus Late Relapse in Triple Negative Breast Cancer Semantic proximity Read

Multi-omic Profiling of Recurrence Risk Across Breast Cancer SubtypesSemantic proximity Read

Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune ActivitySemantic proximity Read

Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer.Semantic proximity Read

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancersSemantic proximity Read

Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive reviewSemantic proximity Read

Molecular intrinsic subtypes, genomic and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancersSemantic proximity Read

Genomic features of rapid versus late relapse in triple negative breast cancer.Semantic proximity Read

Building a genetic and epigenetic predictive model of breast cancer intrinsic subtypes using large-scale data and hierarchical structure learningSemantic proximity Read